These pyrrolidine-spirooxindole molecules in particular have shown a panoply of significant pharmaceutical targets and applications, such as MDM2 inhibitors [20,21,22], anti-cancer treatment [7,23], AChE inhibitors [24,25,26] and prospective activity against SARS-CoV-2 [27]. This evidence concerns the gene ACHE and cancer.